Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC)
(2002) In Journal of Hepatology 36(5). p.586-589- Abstract
- Background/Aims: This study aims at describing the natural history and outcome of small duct primary sclerosing cholangitis (PSC). Methods: Thirty-two patients with small duct PSC were studied. The average time taken for diagnosis was 69 (1-168) months. The median follow-up time was 63 (1-194) months. Results: All patients including one who underwent liver transplantation because of end-stage liver disease and hepatocellular carcinoma were alive at follow-up. None developed cholangiocarcinoma. In 27 patients repeated cholangiographic examinations were done after a median time of 72 (12-192) months from first ERCP. Four developed features of large duct PSC. Conclusions: Small duct PSC rarely progresses to large bile duct PSC and it seems to... (More)
- Background/Aims: This study aims at describing the natural history and outcome of small duct primary sclerosing cholangitis (PSC). Methods: Thirty-two patients with small duct PSC were studied. The average time taken for diagnosis was 69 (1-168) months. The median follow-up time was 63 (1-194) months. Results: All patients including one who underwent liver transplantation because of end-stage liver disease and hepatocellular carcinoma were alive at follow-up. None developed cholangiocarcinoma. In 27 patients repeated cholangiographic examinations were done after a median time of 72 (12-192) months from first ERCP. Four developed features of large duct PSC. Conclusions: Small duct PSC rarely progresses to large bile duct PSC and it seems to have a benign course in most patients and no development of cholangiocarcinoma was found. (C) 2002 European Association for the Study of the Liver. Published by Elsevier Science B.V. All rights reserved. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/336030
- author
- organization
- publishing date
- 2002
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- cholangiocarcinoma, natural history, ulcerative colitis, liver transplantation
- in
- Journal of Hepatology
- volume
- 36
- issue
- 5
- pages
- 586 - 589
- publisher
- Elsevier
- external identifiers
-
- wos:000176015600002
- pmid:11983440
- scopus:0036265139
- ISSN
- 0168-8278
- DOI
- 10.1016/S0168-8278(02)00036-3
- language
- English
- LU publication?
- yes
- id
- 4b9bb9e4-fd58-4aca-9dc2-8ff85cb42ec8 (old id 336030)
- date added to LUP
- 2016-04-01 12:05:35
- date last changed
- 2024-02-23 18:31:47
@article{4b9bb9e4-fd58-4aca-9dc2-8ff85cb42ec8, abstract = {{Background/Aims: This study aims at describing the natural history and outcome of small duct primary sclerosing cholangitis (PSC). Methods: Thirty-two patients with small duct PSC were studied. The average time taken for diagnosis was 69 (1-168) months. The median follow-up time was 63 (1-194) months. Results: All patients including one who underwent liver transplantation because of end-stage liver disease and hepatocellular carcinoma were alive at follow-up. None developed cholangiocarcinoma. In 27 patients repeated cholangiographic examinations were done after a median time of 72 (12-192) months from first ERCP. Four developed features of large duct PSC. Conclusions: Small duct PSC rarely progresses to large bile duct PSC and it seems to have a benign course in most patients and no development of cholangiocarcinoma was found. (C) 2002 European Association for the Study of the Liver. Published by Elsevier Science B.V. All rights reserved.}}, author = {{Broome, U and Glaumann, H and Lindström, Eva and Loof, L and Almer, S and Prytz, Hanne and Sandberg-Gertzen, H and Lindgren, Stefan and Fork, Thomas and Jarnerot, G and Olsson, R}}, issn = {{0168-8278}}, keywords = {{cholangiocarcinoma; natural history; ulcerative colitis; liver transplantation}}, language = {{eng}}, number = {{5}}, pages = {{586--589}}, publisher = {{Elsevier}}, series = {{Journal of Hepatology}}, title = {{Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC)}}, url = {{http://dx.doi.org/10.1016/S0168-8278(02)00036-3}}, doi = {{10.1016/S0168-8278(02)00036-3}}, volume = {{36}}, year = {{2002}}, }